• Correction capabilities of local immunity in women with recurrent vulvovaginal candidiasis
en To content

Correction capabilities of local immunity in women with recurrent vulvovaginal candidiasis

HEALTH OF WOMAN. 2016.5(111):120–125 
 

Correction capabilities of local immunity in women with recurrent vulvovaginal candidiasis 
 

Sukhanov A. A., Savchenko S. E., Kolomiychenko T. V.

Shupyk National Medical Academy of Postgraduate Education, Kiev, Ukraine 
 

The article describes the modern approaches to treatment of recurrent vulvovaginal candidiasis, in particular also focused on the appropriateness of the use of drugs to facilitate the restoration of local immunity of the vagina. From research improve treatment of chronic recurrent vulvovaginal candidiasis with additional application to complex EkoBIOL anticandidal therapy, as evidenced by the 2.7 times the frequency of relapses and

3 times – asymptomatic carriage of Candida. Adverse events or cases of intolerance during the study noted. Concluded that EkoBIOL can be recommended for use in complex antirecurrent therapy in chronic vulvovaginal candidiasis.


Key words: recurrent vulvovaginal candidiasis, therapy, EkoBIOL.


REFERENCES

1. European (IUSTI/ WHO) Guideline on the Management of Vaginal Discharge, 2011 доступно на http://www.iusti.org/regions/europe/pdf/2011/Euro_ Guidelines_ Vaginal_ Discharge_ 2011.Intl_Jrev.pdf

2. Konovalova TS, Stepanenko VI. 2005. Kandydoznyi vulvovahinit: suchasnyi pohliad na problemu. Ukrainskyi zhurnal dermatolohii ta venerolohii 3:219.

3. Fidel P. 2007. History and update on host defense against vaginal candidiasis. Am. J. Reprod. Immunol. 57;1:2–12. http://dx.doi.org/10.1111/j.1600-0897.2006.00450.x; PMid:17156186

4. Tatarchuk TF, Shevchuk TV, Suhorebraya EI. 2007. Hronicheskiy retsidiviruyuschiy kandidoz: prichinyi i posledstviya s pozitsii ginekologa-endokrinologa. Mezhdunarodnyiy endokrinologicheskiy zhurnal 4(10).

5. Stock I. 2010. Fungal diseases of vulva and vagina caused by Candida species. Med. Monatsschr. Pharm. 33;9:324–333. PMid:21192442

6. Shelkovaya NG. 2008. Vulvovaginalnyiy kandidoz: sovremennyiy vzglyad na problemu. Tekst. Novosti meditsinyi i farmatsii 15:14–17.

7. Gubergrits NB, Lukashevich GM i dr. 2005. Kandidoz organov pischevareniya i slizistyih obolochek. Ukrainskiy zhurnal dermatologii i venerologii 3:44–50.

8. Kira EF. 2001. Bakterialnyiy vaginoz. Spb, OOO «Neva-Lyuks»:363

9. Klinichnyi protokol z akusherskoi ta hinekolohichnoi praktyky «Infektsii, shcho peredaiutsia statevym shliakhom», zghidno z nakazom MOZ № 582 vid 15.12.03. K.2007: 200.

10. Hasanova GF, Bondarenko KR, Gaysina YuR i dr. 2007. Mikroekologiya vlagalischa pri disbioze. Mat. 9-go s'ezda VNPOEMP. Moskva:312–313.

11. Kira EF. 2010. Rol probiotikov v lechenii infektsiy vlagalischa. Rossiyskiy vestnik akushera-ginekologa 5:37–42.

12. Guarner F, Khan AG, Garisch J et al. 2008, May. Probiotics and prebiotics. World Gastroenterology Organisation Practice Guideline http://www.worldgastroenterology.org/assets/downloads/en/pdf/guidelines/19_probiotics_prebiotics.pdf

13. Havkin AI. 2006. Mikroflora pischevaritelnogo trakta. M:416.

14. Fаlagas ME, Betsi GI, Athanasiou S. 2006. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. J. Antimicrob. Chemother. 58;2:266–272. http://dx.doi.org/10.1093/jac/dkl246; PMid:16790461